Impact of Shift to Subscription-Based AI and Platform Model

Medical AI (artificial intelligence) company JLK announced through a regulatory filing that its revenue last year increased by 135.2% compared to the previous year.

Jei El Kei company logo. Jei El Kei

Jei El Kei company logo. Jei El Kei

View original image

The company explained that the improvement in performance was driven by a shift in its business structure from a focus on selling individual solutions to a subscription-based AI and platform-based model. It added that the expansion of subscription-based supply contracts and changes in its revenue recognition structure were reflected in the results.


According to JLK, subscription-based supply of its stroke AI solution has expanded, mainly at tertiary general hospitals and regional hub hospitals in Korea. Through a subscription model that links multiple solutions, usage frequency within hospitals has increased, and its base of recurring revenue has also been strengthened.


The company also plans to expand its overseas business. In Japan, it is pursuing both direct sales and partnership strategies based on its stroke AI solution, which has obtained local regulatory approval. In the United States, it is seeking business opportunities mainly with medical institutions and academic societies.



JLK CEO Kim Dongmin said, "The transition of our business model has begun to translate into financial performance," adding, "This year, we plan to increase the proportion of overseas revenue, focusing on Japan and the United States."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing